Ticker · CUSIP 032797300

AVXL

ANAVEX LIFE SCIENCES CORP
Healthcare·Biotechnology
···Share
Holders (tracked)
10
Combined shares
3,513,600
Combined value
$12.51M
Last close
$3.64
Quarter
2025Q4
Price · 1Y$3.64-5.31 (-59.33%)H $13.41 · L $2.74 · Avg Vol 1.6M
$4.00$6.00$8.00$10.00$12.00$14.00VolJul 25Oct 25Jan 26Apr 26
Tracked holders · last 8 quarters
+3 vs previous quarter over the last 8.
1092024Q12025Q4
Price is +2.2% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

12 events
  1. Ken Griffin (Citadel Advisors) trimmed2026-02-17
    −81,986 shares · 2025Q4
    Position
  2. D.E. Shaw & Co. opened position2026-02-17
    +45,000 shares · 2025Q4
    Position
  3. Two Sigma Investments added2026-02-17
    +616,742 shares · 2025Q4
    Position
  4. Steve Cohen (Point72) opened position2026-02-17
    +278,018 shares · 2025Q4
    Position
  5. T. Rowe Price added2026-02-17
    +669 shares · 2025Q4
    Position
  6. Wellington Management trimmed2026-02-17
    −16,582 shares · 2025Q4
    Position
  7. AQR Capital Management added2026-02-17
    +121,779 shares · 2025Q4
    Position
  8. Renaissance Technologies opened position2026-02-12
    +25,422 shares · 2025Q4
    Position
  9. AQR Capital Management trimmed2025-11-14
    −1,027 shares · 2025Q3
    Position
  10. Two Sigma Investments added2025-11-14
    +63,685 shares · 2025Q3
    Position
  11. T. Rowe Price added2025-11-14
    +3,838 shares · 2025Q3
    Position
  12. Wellington Management added2025-11-14
    +93,892 shares · 2025Q3
    Position

Insider activity

No insider transactions in the last 30 days.
View full insider history for AVXL →
Follow-the-investor returns
If you'd copied each holder of AVXL…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
AQR Capital Management2020Q1$3.95-7.8%$545K
Ken Griffin (Citadel Advisors)2016Q2$4.19-13.1%$808K
Ken Griffin (Citadel Advisors)2016Q2$4.19-13.1%$808K
Ken Griffin (Citadel Advisors)2016Q2$4.19-13.1%$808K
Renaissance Technologies2018Q4$4.36-16.4%$93K
Two Sigma Investments2022Q1$5.03-27.7%$6.0M
Steve Cohen (Point72)2023Q4$8.16-55.4%$1.0M
T. Rowe Price2016Q3$8.32-56.3%$168K
Wellington Management2025Q1$8.70-58.2%$991K
D.E. Shaw & Co.2016Q2$9.53-61.8%$164K

Who moved on this name in 2025Q4

Position changes reported for the latest quarter, grouped by direction.
New positions3
Added to3
Trimmed2
Exited0
—

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
8
$77.9M
2022Q2
10
$74.6M
2022Q3
10
$74.2M
2022Q4
10
$69.4M
2023Q1
8
$56.8M
2023Q2
9
$54.8M
2023Q3
9
$51.6M
2023Q4
9
$72.0M
2024Q1
9
$39.5M
2024Q2
10
$37.1M
2024Q3
8
$11.2M
2024Q4
10
$22.5M
2025Q1
9
$15.6M
2025Q2
7
$17.4M
2025Q3
7
$18.4M
2025Q4
10
$12.5M

Who owns AVXL

10 super-investors · 2025Q4
Tracked stake
3.51M
shares
Combined value
$13M
% of shares outstanding
—
shares-out unknown
Quarter action mix
New3Added3Trim4
#ManagerSharesValue
1Two Sigma Investments1.65M$6M
2Ken Griffin
Citadel Advisors
707.3K$3M
3Steve Cohen
Point72
278.0K$990K
4Wellington Management272.2K$969K
5Ken Griffin
Citadel Advisors
222.1K$791K
6AQR Capital Management149.8K$533K
7Ken Griffin
Citadel Advisors
113.7K$405K
8T. Rowe Price46.3K$165K
9D.E. Shaw & Co.45.0K$160K
10Renaissance Technologies25.4K$91K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live AVXL chart.
<iframe src="https://openstocks.me/embed/stock/AVXL" width="100%" height="480" frameborder="0" loading="lazy" title="AVXL chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>
Preview: https://openstocks.me/embed/stock/AVXL